Table 2 Antibiotics resistance pattern in ESBLs and O25b/ST131 clone type isolates of E. coli
Antibiotics | ESBLs samples N = 94 | O25b/ST131 samples N = 79 | ||||
|---|---|---|---|---|---|---|
Resistance | Intermediate | Sensitive | Resistance | Intermediate | Sensitive | |
Ampicillin | 92 (97.9%) | 1 (1.1%) | 1 (1.1%) | 77 (97.4%) | 1 (1.2%) | 1 (1.2%) |
Ampicillin-sulbactam | 87 (92.6%) | 1 (1.1%) | 6 (6.4%) | 72 (91.1%) | 1 (1.2%) | 6 (7.5%) |
Aztreonam | 48 (51.1%) | 1 (1.1%) | 45 (47.9%) | 42 (53.1%) | 1 (1.2%) | 36 (45.5%) |
Cefazolin | 88 (93.6%) | 0 (0.0%) | 6 (6.4%) | 75 (94.9%) | 0 (0.0%) | 4 (5%) |
Cefuroxime | 85 (90.4%) | 0 (0.0%) | 9 (9.6%) | 73 (92.4%) | 0 (0.0%) | 6 (7.5%) |
Ceftriaxone | 82 (87.2%) | 2 (2.1%) | 10 (10.6%) | 71 (89.8%) | 1 (1.2%) | 7 (8.8%) |
Cefotaxime | 85 (90.4%) | 2 (2.1%) | 7 (7.4%) | 72 (91.1%) | 1 (1.2%) | 6 (7.5%) |
Ceftazidime | 24 (25.5%) | 2 (2.1%) | 68 (72.3%) | 22 (27.8%) | 2 (2.5%) | 55 (69.6%) |
Cefepime | 45 (47.9%) | 0 (0.0%) | 49 (52.1%) | 39 (49.3%) | 0 (0.0%) | 40 (50.6%) |